How is Nicotinamide Powder produced?

Nicotinamide Powder, also known as niacinamide powder, is the water-soluble amide form of vitamin B3. It is widely used in skincare, pharmaceuticals, and foods. While several manufacturing routes exist, the biocatalytic process using nitrile hydratase has become a preferred method for producing high-purity nicotinamide powder. This article explains the key stages of that process, from raw material to finished warehouse stock.

 

1. Raw Material: 3-Cyanopyridine

The starting material for biocatalytic nicotinamide powder production is 3-cyanopyridine, a petrochemical derivative. Its quality directly determines the purity profile of the final product. Industrial-grade 3-cyanopyridine is sourced under specification controls, with key impurities monitored before release to production.

2. Biocatalytic Hydration (The Core Step)

In the biocatalytic route, 3-cyanopyridine is converted to nicotinamide by nitrile hydratase, an enzyme produced by microorganisms such as Rhodococcus species. The reaction takes place in an aqueous system under mild temperatures. A landmark study using resting cells of Rhodococcus rhodochrous J1 demonstrated that 12 M 3-cyanopyridine was 100% converted to nicotinamide without formation of nicotinic acid, achieving 1,465 g of nicotinamide per liter in 9 hours. Supplementary lab-scale data with R. rhodochrous PA-34 further confirmed complete conversion of 7 M substrate within 12 hours at 25°C. The enzyme's high selectivity is the key differentiator from chemical hydrolysis, which can produce nicotinic acid as a by-product.

3. Separation and Purification

After hydration, the reaction mixture contains nicotinamide, water, and residual biomass or enzyme carrier. Biomass is removed by centrifugation or membrane filtration. The clarified solution is concentrated under vacuum and crystallized by controlled cooling. Crystallization isolates nicotinamide from trace impurities and produces a uniform crystal habit suitable for drying. The crystallized product is separated by centrifugation and washed with a minimal amount of purified water.

4. Drying and Milling

Wet crystals are dried under vacuum at controlled temperatures to avoid thermal degradation. Vacuum drying is preferred over spray-drying for pharmaceutical-grade material because it operates at lower temperatures and produces a denser, more stable powder. Dried crystals may then be milled to achieve a consistent particle size distribution, depending on whether the customer requires fine powder or granular form.

5. Quality Control and Release Testing

Every batch of nicotinamide powder undergoes release testing before it can be approved for warehousing. For pharmacopeial-grade nicotinamide, USP defines the assay acceptance range as 98.5-101.5% on the dried basis. Typical release tests include:

a. Assay by HPLC (98.5-101.5% on dried basis, per USP)

b. Loss on drying (typically ≤0.5%)

c. Residue on ignition (typically ≤0.1%)

d. Heavy metals (typically ≤ 3 ppm as Pb)

e. Related substances (each unspecified impurity within compendial limits)

Only after all specification tests pass does the batch receive QC release.

6. Packaging and Warehousing

Released nicotinamide powder is packaged in moisture-barrier, light-protective containers. Each package is labeled with product name, batch number, manufacturing date, expiry date, and storage conditions. Packaged goods are transferred to a controlled warehouse maintained at ambient temperature with protection from moisture and direct light. Inventory is managed on a first-expiry-first-out basis, and retention samples from each batch are kept for the full shelf-life period.

 

Compared with conventional chemical hydrolysis, the enzymatic process offers practical advantages for downstream users:

a. Higher selectivity: the Rhodococcus nitrile hydratase system converts 3-cyanopyridine to nicotinamide without generating nicotinic acid.

b. Milder conditions: aqueous, near-neutral, and lower temperature, reducing thermal degradation risks.

c. Cleaner impurity profile: relevant for cosmetic and pharmaceutical applications where trace impurities are tightly controlled.

 

Beyond nicotinamide powder, we supply several specialty ingredients.

Fisetin 50% Extract Powder is a flavonoid found in fruits and vegetables. In human skin cell models, fisetin has been shown to suppress UVB-induced matrix metalloproteinase expression and collagen degradation in dermal fibroblasts, and to protect HaCaT keratinocytes from particulate matter-induced oxidative stress and apoptosis. These are preclinical in vitro findings; human clinical evidence for skin outcomes remains limited.

Water Soluble Resveratrol 10% addresses a documented formulation problem. Native resveratrol has low stability, water insolubility, and poor bioavailability. A water-soluble grade simplifies incorporation into clear beverages, instant drink mixes, and liquid capsules. The value is formulation convenience, not a change in the molecule's intrinsic activity.

Ultramicronized Palmitoylethanolamide is an endogenous fatty acid amide. Its primary mechanism involves PPAR-α activation and inhibition of NF-κB signaling. Clinical studies suggest good safety and tolerability in various pain conditions, though systematic reviews note that overall evidence remains insufficient and larger randomized controlled trials are needed. PEA is typically sold as a nutraceutical ingredient, not a pharmaceutical drug.

Sesamin Powder is a lignan from sesame seeds. In rat hepatocyte studies, sesamin reduced the Δ5 desaturation index without changing Δ5 desaturase mRNA levels. This is a mechanism-level finding; finished-product claims should be reviewed against local supplement regulations.

We are a sophisticated manufacturer and supplier of herbal extracts. Our role is to make your formulation work reliably. Three things we can stand behind:

1. Batch-specific documentation: CoA with HPLC assay, residual solvents, heavy metals, and microbiological data for each lot.

2. Specification flexibility: particle size, bulk density, and packaging can be adjusted to match your existing process.

3. Regulatory support: technical files for your compliance review, including allergen statements, non-GMO declarations, and country-of-origin documentation where applicable.

We do not ask you to take our word for it. Request a sample and a CoA. Run your own tests.

 

If you are evaluating nicotinamide powder or any of the complementary ingredients above, the most useful next step is a specification-level conversation. Tell us:

a. Your target application (skincare, pharmaceuticals, or foods)

b. The grade you need (pharmaceutical, cosmetic, or food-grade)

c. Any process constraints (solubility, particle size, carrier compatibility)

Reach us directly at info@inhealthnature.com. We will reply with a current CoA, a sample offer if appropriate, and a straight answer on lead time and MOQ.

 

References

1. Nagasawa, T., et al. (1988). "Nitrile Hydratase-Catalyzed Production of Nicotinamide from 3-Cyanopyridine in Rhodococcus rhodochrous J1." Applied and Environmental Microbiology, 54(7), 1766–1769. PMID: 16347686.

2. Umeda-Sawada, R., et al. (2003). "Effects of sesamin and capsaicin on the mRNA expressions of delta6 and delta5 desaturases in rat primary cultured hepatocytes." Journal of Nutritional Science and Vitaminology, 49(6), 442–446. PMID: 14974737.

3. Radeva, L., et al. (2025). "Resveratrol-A Promising Therapeutic Agent with Problematic Properties." Pharmaceutics, 17(1), 134. PMID: 39861780.

4. Lang-Illievich K, et al. (2023). "Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials." Nutrients, 15(6), 1350. PMID: 36986081.

5. Chiang, H. M., et al. (2015). "Fisetin Ameliorated Photodamage by Suppressing the Mitogen-Activated Protein Kinase/Matrix Metalloproteinase Pathway and Nuclear Factor-κB Pathways." Journal of Agricultural and Food Chemistry, 63(18), 4551–4560. PMID: 25882230.

6. Molagoda, I. M. N., et al. (2021). "Fisetin Protects HaCaT Human Keratinocytes from Fine Particulate Matter (PM2.5)-Induced Oxidative Stress and Apoptosis by Inhibiting the Endoplasmic Reticulum Stress Response." Antioxidants, 10(9), 1492. PMID: 34573124.